Literature DB >> 9001291

Intensive care of patients with HIV infection: utilization, critical illnesses, and outcomes. Pulmonary Complications of HIV Infection Study Group.

M J Rosen1, K Clayton, R F Schneider, W Fulkerson, A V Rao, J Stansell, P A Kvale, J Glassroth, L B Reichman, J M Wallace, P C Hopewell.   

Abstract

To examine intensive care unit (ICU) admission rates and diagnoses of patients with HIV infection, and to determine the outcomes of different critical illnesses, we analyzed data derived from the 63 patients who were admitted to an ICU from among the 1,130 adults with HIV infection who did not have AIDS at the time of enrollment in a multicenter prospective study. Patients were admitted and treated according to the judgment of their physicians. During 4,298 patient-years of follow-up for the entire cohort, there were 1,320 hospital admissions, of which 68 (5%) included admission to an ICU. Twenty-five (40%) of the patients admitted to the ICU died during that admission. Twenty-four patients (38%) were admitted with a principal diagnosis of lung disease; 11 had Pneumocystis carinii pneumonia (PCP), one of whom was coinfected with Aspergillus fumigatus and Legionella pneumophilia, and six of them (55%) died. Four had bacterial pneumonia, two had pulmonary edema caused by renal failure, and one each had pulmonary tuberculosis, pulmonary Kaposi's sarcoma, pneumothorax, adult respiratory distress syndrome, severe pulmonary fibrosis, cytomegalovirus pneumonitis, and metastatic adenocarcinoma to the lungs. Eleven of these 14 patients (79%) died. Thirty-nine patients had 44 admissions for nonpulmonary diagnoses, including gastrointestinal disorders (14 admissions), cardiovascular disorders (nine), sepsis syndrome (six), neurologic disorders (four), monitoring and ICU nursing care during or after a procedure (four), metabolic disorders (three), trauma (two), drug overdose (one), and unknown reasons (one). Nine (23%) of these patients died. Twenty-eight patients underwent mechanical ventilation, and 16 (57%) died. Seven (25%) had PCP (five died), seven had other primary pulmonary diseases (six died), and 14 were placed on mechanical ventilation for nonpulmonary disorders (five died). Survival did not correlate with CD4 count determined within 6 mo of admission to the ICU. In conclusion, the range of indications for critical care in patients with HIV infection is diverse. PCP accounted for only 16% of the ICU admissions, and mechanical ventilation for PCP and other pulmonary disorders was associated with a high mortality rate. In contrast, mechanical ventilation for nonpulmonary disorders, and admission to the ICU for nonpulmonary diagnoses was associated with a more favorable outcome.

Entities:  

Mesh:

Year:  1997        PMID: 9001291     DOI: 10.1164/ajrccm.155.1.9001291

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

Review 1.  HIV and asthma, is there an association?

Authors:  Jessica A Kynyk; Jonathan P Parsons; Michael F Para; Susan L Koletar; Philip T Diaz; John G Mastronarde
Journal:  Respir Med       Date:  2012-01-27       Impact factor: 3.415

2.  Comparing outcomes of HIV versus non-HIV patients requiring mechanical ventilation.

Authors:  Vikas Pathak; Iliana Samara Hurtado Rendon; Shebli Atrash; Vinay Prasad Rao Gagadam; Kaushik Bhunia; Syam Prasad Mallampalli; Vijay Vegesna; Mahesh Mani Dangal; Ronald L Ciubotaru
Journal:  Clin Med Res       Date:  2011-10-26

Review 3.  Critical illness in HIV-infected patients in the era of combination antiretroviral therapy.

Authors:  Kathleen M Akgün; Laurence Huang; Alison Morris; Amy C Justice; Margaret Pisani; Kristina Crothers
Journal:  Proc Am Thorac Soc       Date:  2011-06

4.  HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era.

Authors:  Kristina Crothers; Laurence Huang; Joseph L Goulet; Matthew Bidwell Goetz; Sheldon T Brown; Maria C Rodriguez-Barradas; Krisann K Oursler; David Rimland; Cynthia L Gibert; Adeel A Butt; Amy C Justice
Journal:  Am J Respir Crit Care Med       Date:  2010-09-17       Impact factor: 21.405

5.  Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection.

Authors:  Elizabeth V Nguyen; Sina A Gharib; Kristina Crothers; Yu-Hua Chow; David R Park; David R Goodlett; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

6.  Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy.

Authors:  Krista Powell; J Lucian Davis; Alison M Morris; Amy Chi; Matthew R Bensley; Laurence Huang
Journal:  Chest       Date:  2008-08-21       Impact factor: 9.410

Review 7.  Clinical review: Respiratory failure in HIV-infected patients--a changing picture.

Authors:  Putul Sarkar; Husham F Rasheed
Journal:  Crit Care       Date:  2013-06-14       Impact factor: 9.097

8.  Epidemiology and Outcomes in Critically Ill Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy.

Authors:  Shannon L Turvey; Sean M Bagshaw; Dean T Eurich; Wendy I Sligl
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-02-27       Impact factor: 2.471

9.  High prevalence of malignancy in HIV-positive patients with mediastinal lymphadenopathy: a study in the era of antiretroviral therapy.

Authors:  Joana Alçada; Magali N Taylor; Penny J Shaw; Sam M Janes; Neal Navani; Robert F Miller
Journal:  Respirology       Date:  2014-01-29       Impact factor: 6.424

10.  Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.

Authors:  Julius J Schmidt; Catherina Lueck; Stefan Ziesing; Matthias Stoll; Hermann Haller; Jens Gottlieb; Matthias Eder; Tobias Welte; Marius M Hoeper; André Scherag; Sascha David
Journal:  Crit Care       Date:  2018-11-19       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.